Fresenius Medical Care AG KGaA Gross Margin 2010-2024 | FMS

Current and historical gross margin for Fresenius Medical Care AG KGaA (FMS) over the last 10 years. The current gross profit margin for Fresenius Medical Care AG KGaA as of March 31, 2024 is %.
Fresenius Medical Care AG KGaA Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-03-31 $21.13B $5.37B 25.41%
2023-12-31 $21.06B $5.33B 25.31%
2023-09-30 $20.82B $5.26B 25.25%
2023-06-30 $20.58B $5.29B 25.69%
2023-03-31 $20.38B $5.42B 26.56%
2022-12-31 $20.44B $5.59B 27.37%
2022-09-30 $20.63B $5.72B 27.75%
2022-06-30 $20.73B $5.85B 28.22%
2022-03-31 $20.87B $5.96B 28.57%
2021-12-31 $20.84B $6.01B 28.82%
2021-09-30 $20.79B $6.09B 29.27%
2021-06-30 $20.71B $6.19B 29.88%
2021-03-31 $20.53B $6.22B 30.32%
2020-12-31 $20.40B $6.33B 31.00%
2020-09-30 $20.21B $6.35B 31.41%
2020-06-30 $19.97B $6.25B 31.29%
2020-03-31 $19.83B $6.16B 31.08%
2019-12-31 $19.57B $6.04B 30.88%
2019-09-30 $19.40B $6.01B 30.97%
2019-06-30 $19.21B $5.99B 31.17%
2019-03-31 $19.35B $6.05B 31.25%
2018-12-31 $19.54B $6.09B 31.15%
2018-09-30 $19.87B $6.28B 31.60%
2018-06-30 $20.25B $6.48B 31.99%
2018-03-31 $20.14B $6.57B 32.61%
2017-12-31 $20.10B $6.79B 33.76%
2017-09-30 $19.55B $6.61B 33.80%
2017-06-30 $19.05B $6.41B 33.62%
2017-03-31 $18.55B $6.16B 33.20%
2016-12-31 $17.91B $5.78B 32.28%
2016-09-30 $17.57B $5.66B 32.20%
2016-06-30 $17.20B $5.57B 32.36%
2016-03-31 $16.98B $5.47B 32.18%
2015-12-31 $16.74B $5.33B 31.85%
2015-09-30 $16.71B $5.28B 31.58%
2015-06-30 $16.59B $5.18B 31.24%
2015-03-31 $16.23B $5.10B 31.41%
2014-12-31 $15.83B $5.00B 31.55%
2014-09-30 $15.38B $4.88B 31.74%
2014-06-30 $14.93B $4.76B 31.90%
2014-03-31 $14.71B $4.71B 32.02%
2013-12-31 $14.61B $4.74B 32.43%
2013-09-30 $14.45B $4.73B 32.74%
2013-06-30 $14.20B $4.67B 32.91%
2013-03-31 $14.02B $4.64B 33.12%
2012-12-31 $13.80B $4.60B 33.35%
2012-09-30 $13.42B $4.52B 33.68%
2012-06-30 $13.24B $4.56B 34.44%
2012-03-31 $13.01B $4.56B 35.02%
2011-12-31 $12.80B $4.52B 35.33%
2011-09-30 $12.64B $4.43B 35.01%
2011-06-30 $12.46B $4.33B 34.73%
2011-03-31 $12.21B $4.22B 34.53%
2010-12-31 $12.05B $4.14B 34.38%
2010-09-30 $11.92B $4.09B 34.30%
2010-06-30 $11.75B $4.01B 34.16%
2010-03-31 $11.57B $3.93B 34.00%
2009-12-31 $11.25B $3.83B 34.08%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $12.100B $21.053B
Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products..
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $218.361B 26.46
Intuitive Surgical (ISRG) United States $151.024B 90.98
Edwards Lifesciences (EW) United States $52.601B 34.23
DexCom (DXCM) United States $46.111B 69.85
Alcon (ALC) Switzerland $44.714B 32.04
IDEXX Laboratories (IDXX) United States $41.624B 48.79
IQVIA Holdings (IQV) United States $38.763B 22.49
STERIS (STE) Ireland $21.579B 25.21
SONOVA HOLDING (SONVY) Switzerland $18.556B 0.00
Waters (WAT) United States $17.496B 25.71
Hologic (HOLX) United States $16.754B 18.74
Sysmex ADR (SSMXY) Japan $9.900B 31.05
Teleflex (TFX) United States $9.811B 15.27
Globus Medical (GMED) United States $8.882B 26.04
Penumbra (PEN) United States $7.279B 82.72
Masimo (MASI) United States $7.203B 41.49
Glaukos (GKOS) United States $5.671B 0.00
TransMedics (TMDX) United States $4.677B 443.78
Integer Holdings (ITGR) United States $3.897B 23.55
PROCEPT BioRobotics (PRCT) United States $3.248B 0.00
Tandem Diabetes Care (TNDM) United States $2.928B 0.00
LivaNova (LIVN) United Kingdom $2.853B 16.94
Inari Medical (NARI) United States $2.634B 0.00
Nihon Kohden (NHNKY) Japan $2.601B 13.78
Elekta AB (EKTAY) Sweden $2.365B 18.13
Integra LifeSciences Holdings (IART) United States $2.305B 10.05
RxSight (RXST) United States $2.141B 0.00
Veracyte (VCYT) United States $1.603B 0.00
Alphatec Holdings (ATEC) United States $1.491B 0.00
Artivion (AORT) United States $0.964B 92.48
AVANOS MEDICAL, INC (AVNS) United States $0.883B 17.18
OPKO Health (OPK) United States $0.871B 0.00
Silk Road Medical (SILK) United States $0.844B 0.00
OrthoPediatrics (KIDS) United States $0.698B 0.00
Pulse Biosciences (PLSE) United States $0.664B 0.00
IRadimed (IRMD) United States $0.548B 30.67
SiBone (SIBN) United States $0.522B 0.00
Paragon 28 (FNA) United States $0.510B 0.00
Mesa Laboratories (MLAB) United States $0.494B 14.66
Pacific Biosciences Of California (PACB) United States $0.479B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.465B 0.00
Treace Medical Concepts (TMCI) United States $0.375B 0.00
AxoGen (AXGN) United States $0.334B 0.00
Nevro (NVRO) United States $0.332B 0.00
Sight Sciences (SGHT) United States $0.326B 0.00
Tactile Systems Technology (TCMD) United States $0.280B 9.58
Semler Scientific (SMLR) United States $0.271B 13.73
AngioDynamics (ANGO) United States $0.246B 0.00
CVRx (CVRX) United States $0.220B 0.00
Delcath Systems (DCTH) United States $0.212B 0.00
908 Devices (MASS) United States $0.200B 0.00
EDAP TMS S.A (EDAP) France $0.200B 0.00
NeuroPace (NPCE) United States $0.186B 0.00
Inogen (INGN) United States $0.172B 0.00
Accuray (ARAY) United States $0.172B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
Atossa Genetics (ATOS) United States $0.151B 0.00
ClearPoint Neuro (CLPT) United States $0.148B 0.00
Yubo Biotech (YBGJ) China $0.123B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
KORU Medical Systems (KRMD) United States $0.098B 0.00
Sensus Healthcare (SRTS) United States $0.087B 18.28
Monogram Orthopaedics (MGRM) United States $0.065B 0.00
EnVVeno Medical (NVNO) United States $0.064B 0.00
InspireMD (NSPR) Israel $0.063B 0.00
Hyperfine (HYPR) United States $0.063B 0.00
Neuronetics (STIM) United States $0.061B 0.00
SEP Acquisition (SEPA) United States $0.055B 0.00
LENSAR (LNSR) United States $0.053B 0.00
Envoy Medical (COCH) United States $0.051B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
Vicarious Surgical (RBOT) United States $0.040B 0.00
Lucid Diagnostics (LUCD) United States $0.039B 0.00
ReWalk Robotics (LFWD) Israel $0.039B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.035B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
Accelerate Diagnostics (AXDX) United States $0.030B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Autonomix Medical (AMIX) United States $0.028B 0.00
Pixie Dust Technologies (PXDT) Japan $0.026B 0.00
Aspira Women's Health (AWH) United States $0.025B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Venus Concept (VERO) Canada $0.006B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
ENDRA Life Sciences (NDRA) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00